The Institute of Cancer Research, London
More than £5 million secured for the ICR from Cancer Research UK’s RadNet programme to fund work in radiotherapy. Cancer Research UK has awarded The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust a substantial £5.14 million through its radiation research network (RadNet) to support pioneering research in radiation therapy.
Our Research - The Institute of Cancer Research, London
The Institute of Cancer Research, London, has been driving scientific discoveries on cancer and its treatment for more than 100 years. We are internationally renowned for our work into cancer genetics, cancer biology and personalised medicine – …
About Us - The Institute of Cancer Research, London
The ICR is led by Chief Executive Professor Kristian Helin, known for his pioneering scientific discoveries in cancer epigenetics.. We are world leaders in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy.. Together with our hospital partner The Royal Marsden NHS Foundation Trust, we are rated as one of the top centres for cancer research and treatment ...
About our research - The Institute of Cancer Research, London
About our research. Cancer is a highly complex disease with more than 200 types, each caused by a different combination of genetic defects. Even among patients with a single type of cancer, such as breast or lung cancer, the genetic triggers vary from one person to the next.
Scientific discoveries - The Institute of Cancer Research, London
Nov 15, 2024 · Scientific discoveries. We have an outstanding record of scientific achievement dating back more than 100 years. Here are some of our most influential discoveries, all of which have played an important role in shaping our modern understanding of cancer and how it …
Academic excellence - The Institute of Cancer Research, London
REF success. We came second in the Times Higher Education league table of university research quality, impact and environment compiled from the most recent Research Excellence Framework (REF 2021).. The ICR was ranked as best in biological sciences, and the third-leading higher education institution in the UK for the impact of our research …
Clinical trials - The Institute of Cancer Research, London
Home to our early-phase trials, the ICR’s and The Royal Marsden’s joint Drug Development Unit (DDU) is one of the leading and largest phase I clinical trials centres in the world.. It brings together lab-based scientists with clinical researchers to run sophisticated phase I trials that match treatments to the precise molecular and genomic profile of patients’ tumours.
Our research excellence - The Institute of Cancer Research, London
The Institute of Cancer Research, London, is the second-ranked academic research centre in the UK - according to the Times Higher Education league table of university research quality and impact compiled from the Research Excellence Framework (REF 2021) - and first for biological sciences. We were ...
Studying and Training - The Institute of Cancer Research, …
The Institute of Cancer Research, London, is the UK’s leading academic research centre and a member institution of the University of London. We are committed to educating and training the next generation of researchers and clinicians. The ICR’s academic success has been recognised by …
Our achievements - The Institute of Cancer Research, London
Our achievements. The Institute of Cancer Research, London, is the second-ranked academic research centre in the UK - according to the Times Higher Education league table of university research quality and impact compiled from the Research Excellence Framework (REF 2021) - and first for biological sciences.. The ICR has been carrying out world-leading research into the causes of cancer, and ...